*Refresh the page if the below document does not appear.
CSL Behring and uniQure’s launched the first ever hemophilia B gene therapy “Hemgenix” with a price tag of a whooping $3.5 Million (₹28 Crore) per dose. The drug is now designated as the most expensive drug in the world.
On Wednesday, Takeda announced that US FDA has accepted and granted priority review of the BLA (Biologics License Application) for TAK-003, the firm’s investigational dengue vaccine candidate.
India’s Union Health Minister Mansukh Mandaviya posted a tweet with an infographic on Wednesday showing that India’s pharma exports have grown 138 percent in AprilOctober 2022-23 as compared to AprilOctober 2013-14.
Aurobindo pharma declared that its unit had inked a licensing pact with Evive Biotech to commercialize the drug Ryzneuta in the US market. The drug is under late-stage review by the US regulatory body for chemotherapyinduced neutropenia.
The EC (European Commission) approved AbbVie’s Skyrizi (risankizumab, 600 mg intravenous [IV] induction, and 360 mg subcutaneous [SC] maintenance therapy) as the first specific interleukin-23 inhibitor indicated for the treatment of adults with moderate to severe active Crohn’s disease.
Indian pharma sector is gazing at 5G as it has the potential to provide excellent bandwidth which can be used to allow faster real-time data transfer of AR (Augmented reality) and VR (Virtual reality) and utilizing IoT, AI and ML in Pharma and healthcare.
Pharma giant Novartis and MMV (Medicines for Malaria Venture) announced on Wednesday that their investigational drug ganaplacide/lumefantrine solid dispersion formulation (SDF) is ready to enter into phase III development.
If you don’t already have an account click the button below to create your account.Create New Account